142 related articles for article (PubMed ID: 31158933)
1. The use of indocyanine green fluorescence angiography to assess perfusion of chronic wounds undergoing hyperbaric oxygen therapy.
Kim DU; Rao A; Kaplan S; Baksh F; Caprioli R; Haight J; Ferguson RG; Pliskin M; Oropallo A
Undersea Hyperb Med; 2018; 45(6):663-671. PubMed ID: 31158933
[TBL] [Abstract][Full Text] [Related]
2. Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment.
Hajhosseini B; Chiou GJ; Virk SS; Chandra V; Moshrefi S; Meyer S; Kamperman KJ; Gurtner GC
Plast Reconstr Surg; 2021 Jan; 147(1):209-214. PubMed ID: 33370067
[TBL] [Abstract][Full Text] [Related]
3. Use of hyperbaric oxygen therapy for tissue ischemia after breast reconstruction.
Rajpal N; Walters ET; Elmarsafi T; Pittman TA; Johnson-Arbor KK
Undersea Hyperb Med; 2019 Jun-Jul-Aug - Third Quarter; 46(4):461-465. PubMed ID: 31509902
[TBL] [Abstract][Full Text] [Related]
4. Visualization of angiogenesis and vasculogenesis in a late tissue radiation injury of the chest wall treated with adjuvant hyperbaric oxygen therapy using fluorescence angiography.
Arnold JF; Marmolejo V
Undersea Hyperb Med; 2019; 46(1):69-73. PubMed ID: 31154687
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study.
Zamboni WA; Wong HP; Stephenson LL; Pfeifer MA
Undersea Hyperb Med; 1997 Sep; 24(3):175-9. PubMed ID: 9308140
[TBL] [Abstract][Full Text] [Related]
6. Hyperbaric oxygen therapy and fluorescence angiography in arterial insufficiency secondary to injection of crushed hydromorphone.
Ray K; Savaser D; Huang E
Undersea Hyperb Med; 2021; 48(3):255-261. PubMed ID: 34390630
[TBL] [Abstract][Full Text] [Related]
7. Impact of hyperbaric oxygen on diabetic ulcers is unaffected by glycemic control.
Bakhtiani P; Mansuri O; Yadav A; Osuoha C; Knight P; Baynosa R; McLafferty R; Jakoby M
Undersea Hyperb Med; 2015; 42(3):183-90. PubMed ID: 26152102
[TBL] [Abstract][Full Text] [Related]
8. Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment.
Mohammad A; Saha S; Escandón JM
Plast Reconstr Surg; 2022 Feb; 149(2):346e-347e. PubMed ID: 34965220
[No Abstract] [Full Text] [Related]
9. Reply: Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment.
Hajhosseini B; Gurtner GC
Plast Reconstr Surg; 2022 Feb; 149(2):347e. PubMed ID: 34965241
[No Abstract] [Full Text] [Related]
10. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
11. Early quantitative evaluation of indocyanine green angiography in patients with critical limb ischemia.
Braun JD; Trinidad-Hernandez M; Perry D; Armstrong DG; Mills JL
J Vasc Surg; 2013 May; 57(5):1213-8. PubMed ID: 23352361
[TBL] [Abstract][Full Text] [Related]
12. Use of in-chamber transcutaneous oxygen measurement to determine optimal treatment pressure in patients undergoing hyperbaric oxygen therapy.
Heyboer M; Byrne J; Pons P; Wolner E; Seargent S; Wojcik SM
Undersea Hyperb Med; 2018; 45(4):389-394. PubMed ID: 30241117
[TBL] [Abstract][Full Text] [Related]
13. Hyperbaric oxygen, oxidative stress, NO bioavailability and ulcer oxygenation in diabetic patients.
Efrati S; Gall N; Bergan J; Fishlev G; Bass A; Berman S; Hamad-Abu R; Feigenzon M; Weissgarten J
Undersea Hyperb Med; 2009; 36(1):1-12. PubMed ID: 19341122
[TBL] [Abstract][Full Text] [Related]
14. Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment.
Jha AK; Bs N; Kumar M; Kumar M
Plast Reconstr Surg; 2021 Dec; 148(6):1064e-1065e. PubMed ID: 34665793
[No Abstract] [Full Text] [Related]
15. Changes in vasomotion--effect of hyperbaric oxygen in patients with diabetes Type 2.
Balaz D; Komornikova A; Sabaka P; Leichenbergova E; Leichenbergova K; Novy M; Kralikova D; Gaspar L; Dukat A
Undersea Hyperb Med; 2016; 43(2):123-34. PubMed ID: 27265989
[TBL] [Abstract][Full Text] [Related]
16. Reply: Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment.
Hajhosseini B; Gurtner GC
Plast Reconstr Surg; 2021 Dec; 148(6):1065e-1066e. PubMed ID: 34665795
[No Abstract] [Full Text] [Related]
17. The effect of hyperbaric oxygen therapy on ischemia-modified albumin levels in people with diabetes with foot ulcers.
Cakmak T; Metin S; Yaman H; Demirbas S; Yildiz S; Turker T; Akin A
Undersea Hyperb Med; 2014; 41(4):277-81. PubMed ID: 25109080
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric medicine for the hospital-based physician.
Weaver LK
Hosp Pract (1995); 2012 Aug; 40(3):88-101. PubMed ID: 23086098
[TBL] [Abstract][Full Text] [Related]
19. Vascular-controlled indocyanine green fluorescence angiography for evaluating locoregional flap perfusion prior to pedicle division.
Wang KC; Lee YC
J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):890-930. PubMed ID: 32981884
[No Abstract] [Full Text] [Related]
20. Use of hyperbaric oxygen on flaps and grafts in China: analysis of studies in the past 20 years.
Zhou YY; Liu W; Yang YJ; Lu GD
Undersea Hyperb Med; 2014; 41(3):209-16. PubMed ID: 24984315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
